Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastases-Reference-Cited by-同舟云学术

Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastases

Published:2017-10-26 Issue:1 Volume:45 Page:48-53
ISSN:0303-6987
Container-title:Journal of Cutaneous Pathology
language:en
Short-container-title:J Cutan Pathol

Author:

Everett Ashlyn S.¹,Pavlidakey Peter G.²,Contreras Carlo M.³,De Los Santos Jennifer F.¹,Kim Ju Y.⁴,McKee Svetlana B.⁵,Kaufman Howard L.⁶,Conry Robert M.⁵

Affiliation:

1. Department of Radiation Oncology; University of Alabama at Birmingham; Birmingham Alabama

2. Dermatopathology Services, Division of Dermatology and Pathology; University of Alabama at Birmingham; Birmingham Alabama

3. Department of Surgery - General Surgery Oncology; University of Alabama at Birmingham; Birmingham Alabama

4. Navigate BioPharma Services, Inc.; A Novartis Subsidiary; Carlsbad California

5. Division of Hematology Oncology; University of Alabama at Birmingham; Birmingham Alabama

6. Department of Surgery and Medicine; Rutgers University; New Brunswick New Jersey

Publisher

Wiley

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cup.13048/fullpdf

Reference9 articles.

1. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma;Andtbacka;J Clin Oncol,2015

2. Talimogene laherparepvec (T-VEC) and other oncolytic viruses for the treatment of melanoma;Bommareddy;Am J Clin Dermatol,2017

3. Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial;Harrington;Onco Targets Ther,2016

4. Role of granulocyte/macrophage colony-stimulating factor in zymocel-induced hepatic granuloma formation;Wynn;Am J Pathol,2001

5. Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis;Szeliga;Tuberculosis (Edinb),2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies;American Journal of Clinical Dermatology;2023-07-03

2. Lyotropic Liquid Crystal Precursor as an Innovative Herpes Simplex Virus Vector for Melanoma Therapy;ASEC 2022;2022-12-01

3. Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma;Melanoma Research;2022-04-21

4. Tumoral Melanosis and Separate Granulomatous Inflammation due to Talimogene Laherparepvec;The American Journal of Dermatopathology;2022-03-01

5. A systematic analysis on the clinical safety and efficacy of onco-virotherapy;Molecular Therapy - Oncolytics;2021-12